* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download A. Glucocorticoid drugs
Pharmaceutical marketing wikipedia , lookup
Drug discovery wikipedia , lookup
Discovery and development of tubulin inhibitors wikipedia , lookup
Environmental impact of pharmaceuticals and personal care products wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Toxicodynamics wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Specialty drugs in the United States wikipedia , lookup
Discovery and development of beta-blockers wikipedia , lookup
Psychedelic therapy wikipedia , lookup
Orphan drug wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmacognosy wikipedia , lookup
Neuropharmacology wikipedia , lookup
Drug interaction wikipedia , lookup
Drugs affecting endocrine system Huifang Tang Department of pharmacology Email: [email protected] Hypothalamus-pituitary gland: The regulatory center of endocrine system Membrane receptor Nuclear receptor (GCS, TH) Part1 Adrenocorticoid drugs Part2 Insulin and oral hypoglycemic drugs Part3 Thyroid hormones and antithyroid drugs Part1 Adrenocorticoid drugs Adrenocortical hormones Mineralocorticoids Glucocorticoids (Glucocorticosteroids) Sex hormones History(1) In 1849, Addison first appreciated the importance of the adrenal glands Addison T. On the Constitutional and Local Effects of Disease of the Supra-renal Capsules. London, UK: Samuel Highley; 1855. Zona Faseciculata Zona Reticularis Androgens Adrenaline Structure and function of adrenal cortex. History(2) As early as 1912, Cushing described patients with hypercorticism, and later recongized that pituitary basophilism represented the cause of the adrenal overactivity. History(3) In 1948, the role of hypothalamus in pituitary control was established by Harris. In 1949, Hench and colleagues demonstrated the dramatic effect of glucocorticoids and ACTH in the treatment of rheumatoid arthritis. Contents A. Glucocorticoid drugs B. Mineralocorticoid drugs C. ACTH and corticosteroid synthetase inhibitors A. Glucocorticoid drugs Basic structure of glucocorticoid drugs: 甾 H A C B D 甾体结构 A. Glucocorticoid drugs Structure and Activity Relationship: (1)1位和2位碳之间改成不饱和的双键: cortisone prednisone; hydrocortisone prednisolone. (2)16引入羟基: triamcinolone(曲安西龙). (3)6引入甲基: 基本结构 6-methylprednisone (6甲基泼尼松). (4)9引入氟原子: H D C fludrocortosone A B (氟氢可的松). 19 1213 18 14 2 1 10 9 8 3 5 4 6 7 16 15 A. Glucocorticoid drugs Mechanisms of glucocorticoid actions binding to glucocorticoid receptor (GR) nuclear translocation binding to GRE or nGRE regulating related gene transcription biological effects (usually slow) Action mode of glucocorticoid drugs CBG: corticosteroid binding globulin S: glucocorticoid steroids GR: glucocorticoid receptor HSP: heat shock protein IP: immunophilin GRE: glucocorticoidresponse element Nuclear translocation of glucocorticoid receptors (GR) Dexamethasone was used GR was labeled with green fluorescent protein A. Glucocorticoid drugs One of glucocorticoid’s anti-inflammatory actions: Inhibition of proinflammatory gene transcription (AP-1 and NFB) Non-genomic mechanisms of action of glucocorticoids. C. Boardman et al. / Pulmonary Pharmacology & Therapeutics 29 (2014) 129e143 A. Glucocorticoid drugs 1. Pharmacological effects Mechanisms of glucocorticoid actions (1) Effects on metabolisms (2) Permissive action (3) Anti-inflammatory effects (4) Effects on immune and allergy (5) Anti-shock (6) Other effects antipyretic effects effects on blood and blood-forming organs skeletal system CNS effects A. Glucocorticoid drugs (1) Effects on metabolisms ①Glucose metabolism: gluconeogenesis, glucose utilization blood glucose. ②Protein metabolism: synthesis, degradation. ③Lipid metabolism: plasma cholesterol, fat redistribution (central obesity: moon face, buffalo hump, etc.). ④Water and electrolytic metabolism: water excretion, Na+ excretion, K+ excretion, Ca2+ excretion and absorption. Weaker action of glucocorticoid drugs (cortisol) on mineralocorticoid receptor A. Glucocorticoid drugs (2) Permissive action Potentiating the effects of catecholamines and glucagon (3) Anti-inflammatory effects Acute: inhibiting microvascular leakage leukocyte infiltration Chronic: inhibiting fibroblast proliferation deposition of collagen cicatrization (瘢痕形成) A. Glucocorticoid drugs a) Increasing inflammation related proteins or enzymes inducing lipocortin(脂皮素), inhibiting phospholipase A2 activity, decreasing mediators: PGs, LTs, PAF inducing angiotension-convertion enzyme,ACE) inducing vasocortin(血管皮素), decreasing microvascular permeability inhibiting the expression of PLA2, COX-2, inducible NOS, etc. b) Inhibiting cytokinins: decreasing the transcription and activities of TNFα, IL-1, IL-2, IL-5, IL-6, IL-8, etc. c) I nhibiting adhesion molecules : decreasing the transcription and activities ofICAM-1, E-selectin etc. d) Inducing the apoptosis of inflammatory cells A. Glucocorticoid drugs (4) Effects on immune and allergy Suppressing immunological functions and allergy a) inducing apoptosis of T and B lymphocytes b) inhibiting transcription factor activity(eg. AP1, NFB): A. Glucocorticoid drugs (5) Anti-shock Septic shock a) improving cardiovascular functions b) inhibiting the production of inflammatory factors c) stabilizing lysosome membrane: decreasing the release of myocardial depressant factor (MDF) d) increasing the tolerance to endotoxin from bacteria A. Glucocorticoid drugs (6) Other effects a) antipyretic effects b) effects on blood and blood-forming organs red cell ; lymphocytes ; neutrophils (function ); eosinophils ; platelets c) skeletal system: osteoporosis d) CNS: increasing excitability (elevated mood, euphoria, insomnia, restlessness, increased motor activity) A. Glucocorticoid drugs 2. ADME and properties of commonly used drugs Cortisone and prednisone are reduced and transformed to hydrocortisone and prednisolone (active forms) in the liver Metabolism will be increased by hepatic enzyme inductors (phenobarbital, phenytoin, rifampine, etc.) A. Glucocorticoid drugs Commonly used drugs Short-acting: hydrocortisone (cortisol) 氢化可的松 cortisone 可的松 Intermediate-acting: prednisone 泼尼松, 强的松 prednisolone 泼尼松龙, 强的松龙 Long-acting: dexamethasone 地塞米松 Topical: fluocinolone 氟轻松 Cortisone Hydrocortisone 可的松 氢化可的松 Cortisol Prednisone 泼尼松 H Prednisolone 泼尼松龙 Fluocinolone 氟轻松 地塞米松 A. Glucocorticoid drugs 3. Clinical uses (1) Immune diseases a) autoimmune disorders: reumatic fever, reumatic carditis, rhumatic arthritis, rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, polyarthritis nodosa, nephritic syndrome, etc. b) rejection of organ transplantation c) allergic diseases: urticaria, serum sickenss, contact dermatitis, drug allergic reactions, chronic severe asthma, status asthmaticus, angioneurotic edema, etc. A. Glucocorticoid drugs (2) Severe infection and inflammation a) acute severe infections: merely suppressing inflammatory manifestations but at times lifesaving Causion: ①combination with effective anti-microbial drugs; ②Large dose; ③short term administration ! Usually be not used in viral and fungal infections except for those with cerebral edema or severe systemic symptoms b) prevention of sequelae (后遗症) of some types of inflammation, such as in brain, heart, eye, joint, etc. A. Glucocorticoid drugs (3) Septic shock: Causion: larger dose, short-term, and combined with antimicrobial drugs. (4) Hemological diseases: acute lymphocytic leukemia, lymphomas, aplastic anemia (再生障碍性贫血),, hemolytic anemia, leukocytopenia, thrombocytopenia, etc. (5) Topical applications: skin, eye, respiratory tract, joint (local injection) (6) Some types of tumors: breast and prostatic cancers, acute lymphocytic leukemia, etc. A. Glucocorticoid drugs 4、Adverse effects of glucocorticoid drugs: Effects resulting from continued used of large doses A. Glucocorticoid drugs 4. Adverse effects (1) Effects resulting from continued used of large doses a) Hypercorticism-like syndrome: central obesity (moon face, buffalo hump, etc.); hypertension; glycosuria, hypokalemia; etc. b) Increasing susceptibility to infections: Causion: specfic antimicrobial drugs should be administered with GCs c) Ingestive system: peptic ulcers, etc. A. Glucocorticoid drugs d) Cardiovascular system: hypertension, arteriosclerosis e) Myopathy and osteoporosis: vertebral compression fractures, spontaneous fractures, especially in postmenopausal women f) CNS: behavioral disturbances, induction of epileptic seizures g) cartarcts(白内障): well established complication of glucocorticoid therapy. Children appear to be particularly at risk. slit-lamp examination h) Inhibition or arrest of growth in children ‒ ACTH Suppression of hypothalamicpituitary-adrenal axis and glucocorticoid drugs A. Glucocorticoid drugs (2) Withdrawal syndrome a) Suppression of hypothalamic-pituitary-adrenal axis b) Exacerbation of the underlying diseases (rebound) (3) Contraindications psychiatric disorders; epilepsy; active peptic ulcers; fractures; hypercorticism; severe hypertension; diabetes mellitus; viral or fungal infections, etc. A. Glucocorticoid drugs Balance the ratio of benefit / risk before the use of GCs !!! A. Glucocorticoid drugs 5. Applications (1) Replacement therapy: usually using hydrocortisone (2) Prompt intensive treatment: i.v. gtt hydrocortisone, dexamethasone (3) Long-term therapy: oral prednisone or prednisolone morning single dose alternate-day therapy Notes: for less severe and less sustained patients; less suppression on hypothalamic-pituitary-adrenal (HPA) axis (4) Tipical applications: skin; eye; respiratory tract B. Mineralocorticoid drugs Aldosterone 醛固酮 Na+ excretion , K+ excretion : edema hypertension hypokalemia, etc. used for adrenocortical dysfunction with imbalance of water and electrolytes Action of aldosterone on mineralocorticoid receptor AIP Mineralocorticoid receptor signal transduction. MR: mineralocorticoid receptor; HRE: hormone responsive element. AIP: Aldosterone induced protein C. Adrenocorticotropic hormone and corticosteroid synthetase inhibitors C. Adrenocorticotropic hormone and corticosteroid synthetase inhibitors 1. Adrenocorticotropic hormone (ACTH) Used for diagnosis of adrenocortical function inhibition of secretion of adrenocortical hoemones after long-term glucocorticoid drug use Easily inducing allergy to ACTH C. Adrenocorticotropic hormone and corticosteroid synthetase inhibitors Extraadrenal effects of Adrenocorticotropic hormone (ACTH) In larger doses, ACTH cause a number of metabolic changes in adrenalectomized animals, including ketosis,lipolysis,hypoglycemia( immediately after treatment) , and resistance to insulin(later after treatment) Hyperpigmentation: ACTH activated the MSH receptor on melanocytes. Diagnosis of H-P-A Axis status: Adrenocortical function test Cosyntropin synthetic ACTH used as adrenal cortical stimulant Normal response: plasma cortisol levels are elevated Abnormal response: plasma cortisol level are unchanged C. Adrenocorticotropic hormone and corticosteroid synthetase inhibitors 2. Inhibitor of the biosythesis Mitotane 米托坦--o,p'-DDD, an adrenocorticolytic agent Corticosteroid synthetase inhibitors inhibit cytochrome P450 enzymes involved in adrenocorticosteroid biosynthesis Metyrapone 美替拉酮 Aminoglutethimide 氨鲁米特 Ketoconazole 酮康唑 target: different steroid hydrolases Used for adrenocortical tumors or hypercorticism Common rsik: precipitating acute adrenal insufficiency C. Adrenocorticotropic hormone and corticosteroid synthetase inhibitors 3、Antiglucocorticoids (抗糖皮质激素药) mifepristone (RU-486) 米非司酮 Antiprogestagen, can terminate early pregnacy. At higher doses, it also inhibits the glucocorticoid receptor, blocking the feedback regulation of HPA axis and secondarily increasing endogenous ACTH and cortisol levels Potential clinicla use: hypercorticism Cortisol Suppression Tests Principle Based on the ability of exogenous cortisol to exert (-) feedback on hypothalamus-pituitary release of ACTH Can’t measure with cortisol itself (exogenous would just replace endogenous) Must use a more potent glucocorticoid derivative usually dexamethasone Diagnosis of H-P-A Axis status: H-P suppression test Dexamethasone: used to evaluate the basis for elevated cortisol levels in individuals with suspected pituitary adenoma (Cushing’s disease) Normal response in Cushing’s disease: plasma ACTH and cortisol, urine 17-OH corticosteroid levels are reduced Abnormal response in cortisol-producing adrenal tumor (low ACTH) or ectopic ACTH-producing tumors (high ACTH): plasma ACTH and cortisol, urine 17-OH corticosteroid levels are unchanged